Diabetic retinopathy (DR) and diabetic macular edema (DME) are two common vision conditions related to diabetes. While both can lead to vision loss, they are different eye conditions. DR is a ...

Eyes of patients with pseudophakic cystoid macular edema demonstrated greater retinal nerve fiber layer (RNFL) thickness compared with healthy eyes. The retinal nerve fiber layer (RNFL) was found to ...

Proliferative diabetic retinopathy is the more advanced stage of the disease. You may experience vision changes and other symptoms. Treatments may include laser or injection therapy. People with ...

Non-proliferative diabetic retinopathy is the earliest stage of this diabetes complication. You may not have symptoms, and medical treatments may not be needed aside from diabetes management. As ...

Credit: Regeneron. Eylea HD is supplied as a sterile, aqueous solution for intravitreal injection in a single-dose vial containing 8mg of aflibercept. The Food and Drug Administration (FDA) has ...

Proliferative diabetic retinopathy (PDR) is the advanced stage of diabetic retinopathy. It involves the development of abnormal retinal blood vessels. The vessels may leak blood and fluid into the ...

People with proliferative diabetic retinopathy may develop another eye condition called macular edema. The macula is the part of the retina that processes the images in the center of your vision ...

– Susvimo can help people with diabetic retinopathy (DR) maintain their vision and prevent progression to blindness with only one treatment every nine months – – Susvimo’s innovative technology via ...

Credit: Genentech. Susvimo is indicated for intravitreal use via the Susvimo ocular implant. For patients with diabetic retinopathy, refills of Susvimo are administered every 36 weeks (approximately 9 ...